Skip to main content
ETON
NASDAQ Life Sciences

Eton Licenses Late-Stage Topical Gel for Infantile Hemangiomas, Targets 2027 NDA

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$46
Mkt Cap
$1.255B
52W Low
$13.985
52W High
$50.18
52W Position info
229% above low
Off High info
8.3% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ETON has more than doubled off its 52-week low of $13.985.

Summary

Eton Pharmaceuticals has licensed U.S. rights to ASN-001, a late-stage topical gel for infantile hemangiomas, from Auson Pharmaceuticals. The product showed strong Phase II/III efficacy: 56% of patients achieved elimination or near-elimination of lesions at 24 weeks with twice-daily dosing, versus 15% on placebo. ASN-001 would be the first FDA-approved topical therapy for this indication, targeting an estimated 20,000–30,000 patients annually who currently use off-label ophthalmic timolol. The deal complements Eton's existing HEMANGEOL franchise, which addresses severe systemic cases, and leverages the same prescriber base. A bioavailability bridging study is planned, with an NDA submission expected in the second half of 2027. This follows a series of insider stock sales in recent months, but the acquisition adds a high-value pipeline asset with patent protection through 2044.

At the time of this announcement, ETON was trading at $46.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $13.99 to $50.18. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ETON - Latest Insights

ETON
Nov 05, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $57.90
Real-time Price: $58.00 info
Change: +$0.0982 (+0.17%) info
Market Cap: $1.348B info
ETON
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $56.06
Real-time Price: $58.00 info
Change: +$1.94 (+3%) info
Market Cap: $1.348B info
ETON
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $47.15
Real-time Price: $58.00 info
Change: +$10.85 (+23%) info
Market Cap: $1.348B info
ETON
Nov 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $47.15
Real-time Price: $58.00 info
Change: +$10.85 (+23%) info
Market Cap: $1.348B info
ETON
Nov 05, 2026, 4:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $58.85
Real-time Price: $58.00 info
Change: -$0.8501 (-1%) info
Market Cap: $1.348B info